skip to content

Evgen Pharma

16:57 on 17/11/2017

Current Price 15.50p | Bid 15.50p | Ask 15.75p | Change 0.00%

Company Overview

Evgen Pharma plc is a clinical stage drug development company. The Group's objective is to establish a dominant position in the development of pharmaceuticals based upon sulforaphane and related analogues. The Group is developing novel therapies for specific cancers (e.g. breast cancer) and neurological diseases such as subarachnoid haemorrhage (a type of stroke) and multiple sclerosis. The Group's core technology is Sulforadex®, a means of synthesising and concurrently stabilising sulforapane or, as more recently demonstrated, novel analogues based upon sulforaphane. Sulforaphane is a plant-derived small molecule with established anti-cancer properties and is a known activator of the Nrf2 pathway. Sulforaphane's clinical and commercial development has, to date, been precluded by the instability of the molecule. The Group utilises its Sulforadex® technology to develop products that exploit the therapeutic properties of sulforaphane and related analogues. The Group's first development product, SFX-01, has completed Phase I trials and has been demonstrated to be safe and well tolerated. Evgen Pharma's strategy is to simultaneously target relatively rare diseases with the potential for orphan designation and conditional marketing authorisations (where a more rapid market approval is possible), alongside larger markets with conventional drug development timelines. This dual track approach affords the Group a balance between the potential for early revenue and the later-stage larger returns predicated on success in major therapeutic markets.

Stock Details

EPIC EVG
ISIN GB00BSVYN304
Shares in Issue 73,142,862
Market cap £ 17.74m
Sector Pharmaceuticals & Biotechnology
Indices FTSE AIM All-Share Index

Info Point:

To buy or sell shares call our Dealing Room on 0113 243 6941

Too much jargon? Our glossary will help make sense of things.

Find out more about our Share Dealing Services.

Price Summary

Mid Price ? 15.63p
Bid Price ? 15.50p
Ask Price ? 15.75p
Volume ? 0
Change Today 0.00p
% Change Today 0.00%
Open 0.00p
Previous Close 15.63p
Intraday High 0.00p
Intraday Low 0.00p
52 Week High 0.00p
52 Week Low 0.00p

Intra-Day Chart

More Charts »

Broker Consensus

The above information represents a selection of the views and target prices published in the last 120 days by analysts in individual stocks. It is subject to change without notice and may not necessarily be the view held by Redmayne-Bentley.

Client Area Access

» Secure Login

» Not registered yet?

Branch Finder

Redmayne-Bentley have High Street branches throughout the UK. Find your nearest branch.